Search

Daniel Lee Traber

from Houston, TX
Age ~86

Daniel Traber Phones & Addresses

  • 4004 Montrose Blvd, Houston, TX 77006
  • 4004 Montrose Blvd #15, Houston, TX 77006
  • 2414 Beluche Dr, Galveston, TX 77551 (409) 744-8459
  • 500 Seawall Blvd #1101, Galveston, TX 77550 (409) 765-1448
  • Fredericksburg, VA
  • Corpus Christi, TX
  • 500 Seawall Blvd, Galveston, TX 77550 (409) 370-2102

Work

Position: Service Occupations

Education

Degree: Bachelor's degree or higher

Emails

Resumes

Resumes

Daniel Traber Photo 1

Casualty Broker

View page
Location:
Houston, TX
Industry:
Insurance
Work:
Marsh Wortham A Division of Marsh Usa
Casualty Broker

Wortham Insurance & Risk Management
Casualty Broker
Education:
Sam Houston State University 2003 - 2007
Bachelors, Bachelor of Business Administration, Finance
Skills:
Commercial Insurance
Casualty
Property and Casualty Insurance
Brokers
General Insurance
Liability
Underwriting
Insurance
Professional Liability
Legal Liability
Workers Compensation
Umbrella Insurance
D&O
Risk Management
Daniel Traber Photo 2

University Professor

View page
Location:
Houston, TX
Industry:
Hospital & Health Care
Work:
Utmb
University Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Daniel L. Traber
Phd
University of Texas Southwestern Medical Center
General Hospital
601 Hubbord Side Dr, Galveston, TX 77555

Publications

Isbn (Books And Publications)

Shock, Sepsis and Organ Failure: Brain Damage Secondary to Hemorrhagic-Traumatic Shock, Sepsis and Traumatic Brain Injury

View page
Author

Daniel L. Traber

ISBN #

3540624198

Us Patents

Therapies For Smoke And/Or Burn Induced Lung Injury

View page
US Patent:
20020044934, Apr 18, 2002
Filed:
Nov 4, 1998
Appl. No.:
09/186726
Inventors:
FRANK C. SCHMALSTIEG - GALVESTON TX, US
DANIEL L. TRABER - GALVESTON TX, US
International Classification:
A61K039/395
US Classification:
424/145100
Abstract:
In accordance with the present invention there are provided therapies for lung injuries following smoke inhalation and thermal injuries. In particular, the invention relates to the use of antibodies, and more particularly human antibodies, as therapeutics of such injuries. In preferred aspects of the invention, antibodies that bind to interleukin-8 (IL-8) and/or L-selectin, alone, or in combination with other antibodies that bind to other pro-inflammatory, inflammatory, and anti-inflammatory moieties that are induced in lung and burn lesions. In particularly preferred embodiments of the invention, human antibodies that bind to IL-8 are utilized and are demonstrated herein to possess therapeutic efficacy in in vivo models of the pro-inflammatory, inflammatory, and anti-inflammatory moieties that are induced in lung and burn lesions.

Treatment Of Lung Disorders

View page
US Patent:
20040192595, Sep 30, 2004
Filed:
Mar 25, 2003
Appl. No.:
10/396855
Inventors:
Kazunori Murakami - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Lillian D. Traber - Galveston TX, US
Donald S. Prough - Galveston TX, US
David N. Herndon - Galveston TX, US
Daniel L. Traber - Galveston TX, US
International Classification:
A61K038/48
US Classification:
514/012000
Abstract:
The invention features methods of treating a subject having a lung disorder such as lung inflammation and injury, by administering antithrombin III by inhalation.

Use Of Aerosolized Antithrombin To Treat Acute Lung Injury

View page
US Patent:
20050169908, Aug 4, 2005
Filed:
Jan 13, 2005
Appl. No.:
11/034590
Inventors:
Kazunori Murakami - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Robert Cox - Galveston TX, US
Hal Hawkins - Galveston TX, US
Lillian Traber - Galveston TX, US
Daniel Traber - Galveston TX, US
International Classification:
A61L009/04
A61K038/48
US Classification:
424094640, 424045000
Abstract:
The invention features methods of treating a subject having a lung disorder such as lung inflammation and injury, by administering antithrombin III through pulmonary delivery.

Method Of Preventing Fibrin Clots In Pulmonary Tissue Through The Use Of Aerosolized Anticoagulants

View page
US Patent:
20050192226, Sep 1, 2005
Filed:
Feb 14, 2005
Appl. No.:
11/057522
Inventors:
Perenlei Enkhbaatar - Galveston TX, US
Kazunori Murakami - Galveston TX, US
Daniel Traber - Galveston TX, US
International Classification:
A61K031/727
A61K038/36
US Classification:
514012000, 514056000
Abstract:
ATIII is a serine proteinase inhibitor (serpin) with anti-coagulant, anti-inflammatory, anti-proliferative and anti-angiogenic properties. The invention features methods of treating a subject having lung injury due to burns and smoke inhalation by administering a synergistic combination of antithrombin III and heparin through pulmonary delivery means.

Pulse Drug Nebulization Systems, Formulations Therefore, And Methods Of Use

View page
US Patent:
20080230053, Sep 25, 2008
Filed:
Sep 14, 2007
Appl. No.:
11/855870
Inventors:
Edward R. Kraft - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Daniel L. Traber - Galveston TX, US
Gabriela A. Kulp - Santa Fe TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61M 11/00
A61K 31/355
US Classification:
12820023, 12820014, 514458
Abstract:
Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damages or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery.

Method Of Preventing Fibrin Clots In Pulmonary Tissue Through The Use Of Aerosolized Anticoagulants

View page
US Patent:
20110070167, Mar 24, 2011
Filed:
Sep 10, 2010
Appl. No.:
12/879235
Inventors:
Perenlei Enkhbaatar - Galveston TX, US
Kazunori Murakami - Galveston TX, US
Daniel L. Traber - Galveston TX, US
International Classification:
A61K 9/12
A61K 38/57
A61P 11/00
A61M 11/00
A61M 15/00
US Classification:
424 43, 514 147, 12820016, 12820315
Abstract:
ATIII is a serine proteinase inhibitor (serpin) with anti-coagulant, anti-inflammatory, anti-proliferative and anti-angiogenic properties. The invention features methods of treating a subject having lung injury due to burns and smoke inhalation by administering a synergistic combination of antithrombin III and heparin through pulmonary delivery means.

Dry Powder Drug Delivery Formulations, Methods Of Use, And Devices Therefore

View page
US Patent:
20120111324, May 10, 2012
Filed:
Oct 22, 2008
Appl. No.:
12/256438
Inventors:
Edward R. Kraft - Galveston TX, US
Stephen L. Hoskins - Galveston TX, US
Perenlei Enkhbaatar - Galveston TX, US
Daniel L. Traber - Galveston TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61M 15/00
A61K 9/14
A61K 9/12
A61P 11/00
A61K 31/522
A61K 31/573
A61K 31/58
A61K 31/137
A61K 38/21
US Classification:
12820315, 514653, 424400, 424 46, 424 854, 51426331, 514171
Abstract:
The present disclosure relates to systems, methods, and formulations for the pulmonary administration of one or more therapeutic agents, in dry powder form, in a single, large dose quantity. These formulations, methods, and systems are useful in the treatment of patients suffering from toxic or harmful gas exposure, such as nerve gas exposure, as well as in the treatment of patients suffering from diseases of the pulmonary system, including tuberculosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD).

Pulse Drug Nebulization System, Formulations Therefore, And Methods Of Use

View page
US Patent:
20120174915, Jul 12, 2012
Filed:
Mar 16, 2012
Appl. No.:
13/423044
Inventors:
Edward R. Kraft - Galveston TX, US
Daniel L. Traber - Galveston TX, US
Gabriela A. Kulp - Santa Fe TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61M 11/00
US Classification:
12820014
Abstract:
Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damaged or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery.
Daniel Lee Traber from Houston, TX, age ~86 Get Report